Authors: Lucas, T Pratscher, B Krishnan, S Fink, D Gunsberg, P Wolschek, M Wacheck, V Muster, T Romirer, I Wolff, K Pehamberger, H Eichler, HG Rangnekar, VM Jansen, B

Citation: T. Lucas et al., Differential expression levels of Par-4 in melanoma, MELANOMA RE, 11(4), 2001, pp. 379-383

Authors: Wacheck, V Heere-Ress, E Halaschek-Wiener, J Lucas, T Meyer, H Eichler, HG Jansen, B

Citation: V. Wacheck et al., Bcl-2 antisense oligonucleotides chemosensitize human gastric cancer in a SCID mouse xenotransplantation model, J MOL MED-J, 79(10), 2001, pp. 587-593

Authors: Halaschek-Wiener, J Wacheck, V Schlagbauer-Wadl, H Wolff, K Kloog, Y Jansen, B

Citation: J. Halaschek-wiener et al., A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cells, MOL MED, 6(8), 2000, pp. 693-704

Authors: Selzer, E Wacheck, V Kodym, R Schlagbauer-Wadl, H Schlegel, W Pehamberger, H Jansen, B

Citation: E. Selzer et al., Erythropoietin receptor expression in human melanoma cells, MELANOMA RE, 10(5), 2000, pp. 421-426

Authors: Jansen, B Wacheck, V Heere-Ress, E Schlagbauer-Wadl, H Hoeller, C Lucas, T Hoermann, M Hollenstein, U Wolff, K Pehamberger, H

Citation: B. Jansen et al., Chemosensitisation of malignant melanoma by BCL2 antisense therapy, LANCET, 356(9243), 2000, pp. 1728-1733

Authors: Jansen, B Graselli, U Dallinger, S Kiss, B Wacheck, V Schlagbauer-Wadl, H Assandri, A Muller, M

Citation: B. Jansen et al., Pharmacokinetics and pharmacodynamics of the novel H-1-receptor antagonistemedastine in healthy volunteers, EUR J CL PH, 55(11-12), 2000, pp. 837-841